WIPO
open access
CC BY 4.0
Conflicts between pharmaceutical patents and access to medicine during the pandemic
Resolved via OpenAlex (WIPO collection).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Patents for pharmaceuticals and access to affordable medicines: towards an all-encompassing access paradigm for Africa#1181295
- The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026 (2026)#278239
- TRIPS and Pharmaceutical Patents : Effects on Access to Essential Medicine and Innovation#1181291
- Public Hawking of Medicines: The Blind Spot in Medicines Regulation#306936
- Sequential analysis for post-marketing drug safety surveillance using routinely collected electronic healthcare data: a scoping review.#354638
Record · ID 1181292
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive